Brief Information of the Cell Line and Protein
Cell Line ID: CL000048 , PC-3
Synonyms
PC3
PC.3
Category Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0035
Protein ID: PT03794 , Integrin alpha-V
Gene Name ITGAV
Organism Homo sapiens, Human
Protein Classification Membrane receptor
Uniprot ID P06756
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000048  Protein ID: PT03794
 
Compound ID Compound Name Compound Formula
CP0636915
2-[(2S,5R,8S,11S)-5-benzyl-11-(3-carbamimidamidopropyl)-8-({4-[(2-{2-[2-({N'-[(1E)-[(19S)-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-10-yl]methylidene]hydrazinecarbonyl}methoxy)ethoxy]ethoxy}acetamido)methyl]phenyl}methyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl]acetic acid
   Show/Hide
C60H69N13O16
 1
1
IC50 = 4800 nM
   TI
   LI
   LO
   TS
CP0000897
2-[(2S,5R,8S,11S)-5-benzyl-11-(3-carbamimidamidopropyl)-8-{3-[(2-{[(Z)-{[(19S)-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-10-yl]methylidene}amino]oxy}ethyl)carbamoyl]propyl}-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl]acetic acid
   Show/Hide
C50H58N12O13
 1
1
IC50 = 5800 nM
   TI
   LI
   LO
   TS
CP0004991
2-[(2S,5R,8S,11S)-5-benzyl-11-(3-carbamimidamidopropyl)-8-{[4-({2-[2-(2-{[(2-{[(E)-{[(19S)-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-10-yl]methylidene}amino]oxy}ethyl)carbamoyl]methoxy}ethoxy)ethoxy]acetamido}methyl)phenyl]methyl}-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl]acetic acid
   Show/Hide
C62H73N13O17
 1
1
IC50 = 8300 nM
   TI
   LI
   LO
   TS
CP0637030
2-[(2S,5R,8S,11S)-5-benzyl-11-(3-carbamimidamidopropyl)-8-({4-[(2-{2-[2-({N'-[(1E)-3-[(19S)-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-10-yl]propylidene]hydrazinecarbonyl}methoxy)ethoxy]ethoxy}acetamido)methyl]phenyl}methyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl]acetic acid
   Show/Hide
C62H73N13O16
 1
1
IC50 = 11000 nM
   TI
   LI
   LO
   TS
CP0011035
2-((2S,5R,8S,11S)-5-benzyl-11-(3-guanidinopropyl)-8-(4-(13-hydrazinyl-3,13-dioxo-5,8,11-trioxa-2-azatridecyl)phenyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid
   Show/Hide
C38H53N11O12
 1
1
IC50 = 15600 nM
   TI
   LI
   LO
   TS
CP0633534
1-(4-((5S,11S,14R)-14-benzyl-11-(carboxymethyl)-5-(3-guanidinopropyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)phenyl)-3-oxo-5,8,11-trioxa-2-azatridecan-13-oic acid
   Show/Hide
C38H51N9O13
 1
1
IC50 = 18800 nM
   TI
   LI
   LO
   TS
CP0004329
4-(4-((2S,5S,11S,14R)-14-benzyl-11-(carboxymethyl)-5-(3-guanidinopropyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)benzylamino)-4-oxobutanoic acid
   Show/Hide
C34H43N9O10
 1
1
IC50 = 33700 nM
   TI
   LI
   LO
   TS
CP0004249
4-((2S,5S,11S,14R)-14-benzyl-11-(carboxymethyl)-5-(3-guanidinopropyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)butanoic acid
   Show/Hide
C27H38N8O9
 1
1
IC50 = 38800 nM
   TI
   LI
   LO
   TS
CP0001576
2-[(2S,5R,8S,11S)-5-benzyl-11-(3-carbamimidamidopropyl)-8-{[4-({3-[(2-{[(E)-{[(19S)-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-10-yl]methylidene}amino]oxy}ethyl)carbamoyl]propanamido}methyl)phenyl]methyl}-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl]acetic acid
   Show/Hide
C58H65N13O14
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS